Globus Medical (GMED) Shares Outstanding (Weighted Average) (2011 - 2026)

Globus Medical has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $135.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 1.02% year-over-year to $135.4 million; the trailing twelve-month figure through Mar 2026 stood at $135.4 million (down 1.02% YoY), and the FY2025 full-year result was $135.2 million, changed 0.38% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $135.4 million, roughly flat from $135.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $136.8 million in Q1 2025, with the low at $100.3 million in Q1 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $120.6 million across 5 years, with a median of $134.5 million in 2025.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) declined 1.3% — and 2024, when it jumped 34.98%.
• Globus Medical's Shares Outstanding (Weighted Average) stood at $100.5 million in 2022, then increased by 12.56% to $113.1 million in 2023, then climbed by 20.02% to $135.7 million in 2024, then dropped by 0.38% to $135.2 million in 2025, then grew by 0.11% to $135.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $135.4 million (Q1 2026), $135.2 million (Q4 2025), and $134.5 million (Q3 2025), per Business Quant data.